Skip to content
Sail Logo
  • Our Science
  • Our Programs
  • About Us
  • Careers
  • Newsroom
  • Contact
Sail Logo
  • Our Science
  • Our Programs
  • About Us
  • Careers
  • Newsroom
  • Contact

140 First Street,
Cambridge, MA 02141

LinkedInTwitter

News & Press

Featured

Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025

BusinessWire •

May 13, 2025

Read More

Press Releases

Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors

October 23, 2025

Sail Biomedicines to Present New Preclinical Data on Malaria eRNA™ Vaccine Candidates at the 2025 Grand Challenges Annual Meeting

June 2, 2025

Q&A: Is the key to personalised medicine programmability?

Pharmaceutical Manufacturer •

May 30, 2025

Designing Our Way Toward Circular RNA Medicines With AI

Advancing RNA •

May 30, 2025

Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025

BusinessWire •

May 13, 2025

Rajesh Ramaswamy: Teaching Machines to Generate Tomorrow's Medicines

January 8, 2025

Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board

Business Wire •

April 2, 2024

Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines

Business Wire •

January 5, 2024

Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board

Business Wire •

January 4, 2024

Load More

Press Releases

Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors

October 23, 2025

  • Our Science
  • Our Programs
  • About Us
  • Careers
  • Newsroom
  • Contact
Sail Logo

140 First Street,
Cambridge, MA 02141

LinkedInTwitter

© Copyright 2025 Sail Biomedicines

  • Terms of Service
  • Privacy Policy